Otieno C F, Kayima J K, Mbugua P K, Amayo A A, Mcligeyo S O
Department of Clinical Medicine and Therapeutics, College of Health Sciences, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya.
East Afr Med J. 2010 Feb;87(2):66-73. doi: 10.4314/eamj.v87i2.60600.
In spite of many advances in the management of diabetes in the last 25 years, the mortality associatedwith diabetic ketoacidosis (DKA) remains high, especially in the developing countries. The mortality appears greatest in the first 24-48 hours of their treatment. Most of the previous studies on DKA focused on children and the precipitating factors thereof but not particularly on clinical predictors of outcomes.
To determine the clinico-laboratory predictors of outcomes of patients hospitalised with diabetic ketoacidosis who were undergoing treatment.
Cross-sectional descriptive study.
The accident and emergency department and medical wards of the Kenyatta National Hospital.
Fifty one patients hospitalised with diabetic ketoacidosis over a nine month period were evaluated clinically and by laboratory tests. They were managed in the standard way with insulin, intravenous fluids and appropriate supportive care.
Serial assays of serum electrolytes, glucose and blood pH, HbA1c and clinical outcome of either discharge home or death.
Of the 51 patients enrolled, 47 were included in the final analysis. Fourteen (29.8%) patients died,andthe deaths occurred within less than48 hours of hospitalisation and treatment. Of the patients who died, all (100%) had altered level of consciousness at hospitalisation, 71.4% had abnormal renal functions, 64.3% were newly diagnosed and an equal proportion of 64.3% were females. The alteration in the level of consciousness was significantly associated systolic hypotension and severe metabolic acidosis, (p < 0.001). Patients with altered level of consciousness also had poorer renal function.
Apparently DKA still carries high mortality during treatment in hospital. Altered level of consciousness, which is an obvious and easily discernible clinical sign, was a major predictor of mortality in our study patients. The majority of patients with altered level of consciousness also had systolic hypotension, severe metabolic acidosis and impaired renal function. Even where and when detailed laboratory evaluation is elusive, clinical signs, especially altered level of consciousness and systolic hypotension are very important markers of severity of DKA that may be associated with unfavourable outcomes. Further studies are necessary to establish why DKA still carries high mortality in the patients who are already receiving treatment in hospitals in developing countries.
尽管在过去25年中糖尿病管理取得了许多进展,但与糖尿病酮症酸中毒(DKA)相关的死亡率仍然很高,尤其是在发展中国家。死亡率似乎在治疗的最初24 - 48小时内最高。以前关于DKA的大多数研究集中在儿童及其诱发因素上,而不是特别关注结局的临床预测因素。
确定接受治疗的糖尿病酮症酸中毒住院患者结局的临床实验室预测因素。
横断面描述性研究。
肯雅塔国家医院的急诊科和内科病房。
对在9个月期间因糖尿病酮症酸中毒住院的51例患者进行了临床评估和实验室检查。他们接受胰岛素、静脉输液和适当支持治疗的标准管理。
血清电解质、血糖和血液pH值的系列测定、糖化血红蛋白(HbA1c)以及出院回家或死亡的临床结局。
在纳入的51例患者中,47例纳入最终分析。14例(29.8%)患者死亡,死亡发生在住院和治疗后不到48小时内。在死亡患者中,所有患者(100%)住院时意识水平改变,71.4%肾功能异常,64.3%为新诊断患者,女性占64.3%。意识水平改变与收缩期低血压和严重代谢性酸中毒显著相关(p < 0.001)。意识水平改变的患者肾功能也较差。
显然,DKA在住院治疗期间仍具有高死亡率。意识水平改变是一个明显且易于识别的临床体征,是我们研究患者死亡率的主要预测因素。大多数意识水平改变的患者还伴有收缩期低血压、严重代谢性酸中毒和肾功能受损。即使在无法进行详细实验室评估的情况下,临床体征,尤其是意识水平改变和收缩期低血压,也是DKA严重程度的非常重要的标志物,可能与不良结局相关。有必要进一步研究为何在发展中国家已经住院接受治疗的患者中DKA仍具有高死亡率。